Related Experiment Video
Updated: Jun 6, 2025
03:47
Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
Published on: September 27, 2024
796
A Multimodal Approach to Acne-Induced Post-Inflammatory Hyperpigmentation: Trifarotene as a Long-Term Intervention
1Division of Dermatology, McGill University, Montréal, QC, Canada.
Skin Therapy Letter
|November 22, 2024
Summary
Acne sequelae like hyperpigmentation are distressing. Trifarotene, a novel topical retinoid, shows efficacy in treating acne-induced hyperpigmentation, offering a new evidence-based option.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Acne vulgaris is a common chronic skin condition affecting the pilosebaceous unit.
- Acne sequelae, such as scarring and post-inflammatory hyperpigmentation (PIH), significantly impact patient distress.
- Effective management of PIH is crucial, often requiring targeted therapeutic interventions.
Purpose of the Study:
- To review current treatment modalities for post-inflammatory hyperpigmentation.
- To present trifarotene as a novel topical therapeutic option for acne-induced PIH.
Main Methods:
- Literature review of treatment options for PIH.
- Analysis of clinical data supporting trifarotene's efficacy in PIH.
Main Results:
- Trifarotene demonstrates efficacy in managing moderate-to-severe facial and truncal acne.
- Emerging data supports trifarotene's effectiveness in treating acne-induced hyperpigmentation.
Conclusions:
- Trifarotene is a promising, evidence-based topical treatment for acne-induced PIH.
- Novel retinoids offer new avenues for managing distressing acne sequelae.
